100 Dispersible Aspirin Tablets 75mg

100 Dispersible Aspirin Tablets 75mg

Aspirin Dispersible Tablets 75mg can help to prevent heart attacks and strokes in patients with previous history of these conditions. Can also be used following bypass surgery. PLEASE NOTE THAT THESE TABLETS ARE NOT SUITABLE FOR GENERAL PAIN RELIEF - the Aspirin 300mg tablets are suitable for this purpose

100 Dispersible Aspirin Tablets 75mg

Adults: One or two tablets daily, dissolved in water, after food. Not to be given to children under 16 years.

100 Dispersible Aspirin Tablets 75mg

• There is a possible association between aspirin and Reye's syndrome when given to children. Reye's syndrome is a very rare disease, which affects the brain and liver, and can be fatal. For this reason aspirin should not be given to children aged under 16 years unless specifically indicated (e.g. for Kawasaki's disease).
  Salicylates may enhance the effect of oral hypoglycaemic agents, phenytoin and sodium valproate. They inhibit the uricosuric effect of probenecid and may increase the toxicity of sulphonamides.
   
  Aspirin may potentiate the effect of heparin and increases the risk of bleeding with oral anticoagulants, antiplatelet agents and fibrinolytics.  
  Plasma salicylate concentrations may be reduced by concurrent use of corticosteroids, and salicylate toxicity may occur following withdrawal of the corticosteroids. The risk of gastrointestinal ulceration and bleeding may be increased when aspirin and corticosteroids are co-administered.  
  Concurrent use of aspirin and other NSAIDs should be avoided. Use of two or more NSAID preparations increases the risk of serious gastrointestinal haemorrhage.  
  Concurrent administration of carbonic anhydrase inhibitors such as acetazolamide and salicylates may result in severe acidosis and increased central nervous system toxicity.  
  In large doses, salicylates may also decrease insulin requirements.  
  Patients using enteric coated aspirin should be advised against ingesting antacids simultaneously to avoid premature drug release.  
  
   
  Before commencing long-term aspirin therapy for the management of cerebrovascular or cardiovascular disease patients should consult their doctor who can advise on the relative benefits versus the risks for the individual patient.
   
  Aspirin decreases platelet adhesiveness and increases bleeding time. Haematological and haemorrhagic effects can occur, and may be severe. Patients should report any unusual bleeding symptoms to their physician.
   
  Salicylates should be used with caution in patients with a history of peptic ulceration or coagulation abnormalities. They may also induce gastro-intestinal haemorrhage, occasionally major.
   
  They may also precipitate bronchospasm or induce attacks of asthma in susceptible subjects.
   
  Aspirin should be used with caution in patients with impaired renal function (avoid if severe), or in patients who are dehydrated.
   
  Patients with hypertension should be carefully monitored.

You should carefully read all product packaging and labels prior to use

People who are sensitive to aspirin may have reactions, such as asthma attacks and skin rashes. 
 Aspirin may induce gastric irritation, nausea or dyspepsia

100 Dispersible Aspirin Tablets 75mg

Aspirin Dispersible Tablets 75mg

100 Dispersible Aspirin Tablets 75mg